Targeted gene therapy and cell reprogramming in Fanconi anemia

Targeted gene therapy and cell reprogramming in Fanconi anemia

Abstract Gene targeting is progressively becoming a realistic therapeutic alternative in clinics. It is unknown, however, whether this technology will be suitable for the treatment of DNA repair deficiency syndromes such as Fanconi anemia (FA), with defects in homology‐directed DNA repair. In this s...

Full description

Bibliographic Details
Main Authors: Paula Rio, Rocio Baños, Angelo Lombardo, Oscar Quintana‐Bustamante, Lara Alvarez, Zita Garate, Pietro Genovese, Elena Almarza, Antonio Valeri, Begoña Díez, Susana Navarro, Yaima Torres, Juan P Trujillo, Rodolfo Murillas, Jose C Segovia, Enrique Samper, Jordi Surralles, Philip D Gregory, Michael C Holmes, Luigi Naldini, Juan A Bueren
Format: Article
Language:English
Published: Springer Nature 2014-06-01
Series:EMBO Molecular Medicine
Subjects:
cell reprogramming
Fanconi anemia
gene‐targeting
iPSCs
zinc finger nucleases
Online Access:https://doi.org/10.15252/emmm.201303374

Internet

https://doi.org/10.15252/emmm.201303374

Similar Items